Literature DB >> 2531034

Release of prostaglandin E2 from cells by photodynamic treatment in vitro.

B W Henderson1, J M Donovan.   

Abstract

Photodynamic treatment in vitro, using the photosensitizer Photofrin II and light at 630 nm, was found to liberate large amounts of prostaglandin E2 (PGE2) from mouse radiation-induced fibrosarcoma tumor cells and peritoneal macrophages, but not from L929 fibroblasts. PGE2 release was dose dependent and directly related to cell membrane disruption. It occurred rapidly and was complete within 30 min of treatment. PGE2 release could be inhibited by indomethacin, meclofenamate and extended prior exposure to dexamethasone, indicating that it was due to new production involving both the phospholipase and cyclooxygenase enzyme systems. Removal of calcium ions, necessary for phospholipase activation, from the medium did not inhibit the photodynamically induced elevated PGE2 production, possibly because of Ca2+ resupply from leaking intracellular pools.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2531034

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  28 in total

1.  Lipid composition affects the rate of photosensitized dissipation of cross-membrane diffusion potential on liposomes.

Authors:  Shany Ytzhak; Joseph P Wuskell; Leslie M Loew; Benjamin Ehrenberg
Journal:  J Phys Chem B       Date:  2010-08-12       Impact factor: 2.991

Review 2.  Photodynamic therapy in the biliary tract.

Authors:  M Ortner
Journal:  Curr Gastroenterol Rep       Date:  2001-04

Review 3.  Photodynamic therapy and anti-tumour immunity.

Authors:  Ana P Castano; Pawel Mroz; Michael R Hamblin
Journal:  Nat Rev Cancer       Date:  2006-07       Impact factor: 60.716

4.  Photodynamic therapy with verteporfin for retinal angiomatous proliferation.

Authors:  Francesco Boscia; Maurizio Battaglia Parodi; Claudio Furino; Michele Reibaldi; Carlo Sborgia
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-03-09       Impact factor: 3.117

Review 5.  Mechanisms of resistance to photodynamic therapy.

Authors:  A Casas; G Di Venosa; T Hasan
Journal:  Curr Med Chem       Date:  2011       Impact factor: 4.530

6.  Mechanisms in photodynamic therapy: part two-cellular signaling, cell metabolism and modes of cell death.

Authors:  Ana P Castano; Tatiana N Demidova; Michael R Hamblin
Journal:  Photodiagnosis Photodyn Ther       Date:  2005-03       Impact factor: 3.631

Review 7.  Endoscopic palliation of malignant biliary strictures.

Authors:  Sanjay M Salgado; Monica Gaidhane; Michel Kahaleh
Journal:  World J Gastrointest Oncol       Date:  2016-03-15

Review 8.  The role of photodynamic therapy for hilar cholangiocarcinoma.

Authors:  Young Koog Cheon
Journal:  Korean J Intern Med       Date:  2010-11-27       Impact factor: 2.884

9.  Cyclooxygenase-2 expression in esophageal epithelium before and after photodynamic therapy for Barrett's esophagus with high-grade dysplasia or intramucosal carcinoma.

Authors:  Patrick Yachimski; Mari Mino-Kenudson; Margaret E Sherwood; William P Puricelli; Norman S Nishioka; Gregory Y Lauwers
Journal:  Virchows Arch       Date:  2011-11-13       Impact factor: 4.064

Review 10.  Photodynamic Therapy and Immunity: An Update.

Authors:  Riddhi Falk-Mahapatra; Sandra O Gollnick
Journal:  Photochem Photobiol       Date:  2020-04-23       Impact factor: 3.421

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.